Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03488264 · ClinicalTrials.gov registry record
Stigma, Self-management, & Quality of Life in SCD
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 102
- Enrollment target
NCT03488264 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 102 participants.
The verdict
NCT03488264 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
Many individuals with sickle cell disease experience both a poor quality of life and stigma. Individuals with SCD often experience high levels of stigma which can be a barrier to good self-management and hinder quality of life. The purpose of this research is to improve understanding of the relationships between stigma, self-management, and quality of life in SCD in the United States and Jamaica. The findings from this project will contribute to the development of a tool to measure self-management strategies and will also guide the development of interventions to improve SCD self-management.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2018-02-13 |
| Est. Completion | 2018-10-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03488264
The ClinicalTrials.gov registry entry for NCT03488264 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03488264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03488264 about?
NCT03488264 is a clinical study titled "Stigma, Self-management, & Quality of Life in SCD". Many individuals with sickle cell disease experience both a poor quality of life and stigma. Individuals with SCD often experience high levels of stigma which can be a barrier to good self-management and hinder quality of life. The purpose of this research is to improve understanding of the relation...
What is the current status of trial NCT03488264?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2018-02-13. Estimated completion is 2018-10-27.
Who is sponsoring clinical trial NCT03488264?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.